Sangamo Therapeutics France Competitors and Similar CompaniesClear all
Sangamo Therapeutics France's competitors and similar companies include Bioz, Karius, eGenesis and Dicerna Pharmaceuticals.
 Sangamo Therapeutics France Sangamo Therapeutics France (formerly known as TxCell) is a biotechnology company that develops platforms for innovative, personalized T cell immunotherapies for the treatment of severe inflammatory and autoimmune diseases with high unmet medical needs. |  Karius Karius is a life sciences company focused on conquering infectious diseases through the innovative use of next-generation sequencing to analyze microbial cell-free DNA. |  Dicerna Pharmaceuticals Dicerna Pharmaceuticals is a clinical-stage biopharmaceutical company that focuses on the discovery and development of treatments for rare inherited diseases. | |||
Founding Date | Founding Date 2001 | Founding Date 2013 | Founding Date 2014 | Founding Date 2015 | Founding Date 2007 |
Type | Type Subsidiary | Type Private | Type Private | Type Private | Type Subsidiary |
Tags | |||||
Locations | Locations Valbonne, FR HQ | Locations Palo Alto, US HQ | Locations Redwood City, US HQ | Locations Cambridge, US HQ | Locations Cambridge, US HQ Boulder, US Lexington, US |
Employees | Employees 7 | Employees 542% decrease | Employees 205 | Employees 1332% increase | Employees 1042% decrease |
Financial | |||||
Revenue (est.) | Revenue (est.) €2.2m (FY, 2017) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $164.3m (FY, 2020) |
Net income | Net income (€10.9m) (FY, 2017) | Net income N/A | Net income N/A | Net income N/A | Net income ($112.7m) (FY, 2020) |
Operating ⚠ | |||||
Trademarks (US) | Trademarks (US) N/A | Trademarks (US) 7 (Jun, 2024) | Trademarks (US) N/A | Trademarks (US) 2 (Sep, 2022) | Trademarks (US) N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 3m (almost 10 years ago) | Latest funding round $ 165m (over 6 years ago) | Latest funding round $ 125m (over 5 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 71.6m | Total funding raised $ 3m | Total funding raised $ 220m | Total funding raised $ 265m | Total funding raised $ 287.1m |
For sources of this data, please see the company profile
View Company Profiles
Bioz
HQ
Palo Alto, US
Employees
54↓ 2% decrease
Bioz is a company that develops an AI search engine for life science experimentation.
View companyKarius
HQ
Redwood City, US
Employees
205
Karius is a life sciences company focused on conquering infectious diseases through the innovative use of next-generation sequencing to analyze microbial cell-free DNA.
View company
eGenesis
HQ
Cambridge, US
Employees
133↑ 2% increase
eGenesis is a biotechnology company that develops human-compatible (HuCo) organs and cells.
View companyDicerna Pharmaceuticals
HQ
Cambridge, US
Dicerna Pharmaceuticals is a clinical-stage biopharmaceutical company that focuses on the discovery and development of treatments for rare inherited diseases.
View company